Business Context and Reporting Period
This Form 8-K is filed by Second Sight Medical Products, Inc. (not Vivani Medical, Inc.) on April 11, 2019. The report discloses a scientific presentation regarding the Orion Visual Cortical Prosthesis System at the Fifth Annual BRAIN Initiative Investigators Meeting in Washington, D.C.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a scientific update and regulatory disclosure rather than financial performance.
Material Changes
No material financial changes versus a prior period are reported. The material event is the announcement of positive interim results from the Early Feasibility Study of the Orion Visual Cortical Prosthesis System.
Guidance, Outlook, and Risks
- Management Commentary: Dr. Jessy D. Dorn, Sr. Director of Scientific Research, presented an update on the Orion system.
- Outlook: The company presented "Positive Interim Results" regarding the feasibility study.
- Disclaimers: The company specifically disclaims any obligation to update the poster or presentation materials in the future or to reflect events occurring after the date of this report.
- Regulatory Status: The information in the exhibits is not deemed "filed" for purposes of Section 18 of the Exchange Act unless expressly incorporated by reference.
Investor Verification Checklist
- Verify the specific clinical data points in the attached Exhibit 99.2 (Poster) and Exhibit 99.3 (Presentation Materials).
- Confirm the timeline for the next phase of the Orion Visual Cortical Prosthesis System trials.
- Review the press release (Exhibit 99.1) for details on the "positive interim results" mentioned.
- Note that this filing contains no financial statements; refer to the most recent 10-K or 10-Q for financial health.